Stem Cell Injections and Other Regenerative Treatments

The short answer

Stem cell injections, BMAC, amniotic products, exosomes, prolotherapy, fat injections — patients ask me about all of these, usually after finding a clinic advertising one of them for three to five thousand dollars.

They are all trying to accomplish the same thing: getting growth factors into a worn joint to stimulate a healing response. That idea is legitimate. The question worth asking is which of them actually delivers on it, at what cost, and with what evidence behind it.

The conversation I have in the office

When someone comes in asking about stem cells, I do not think the useful response is to wave the question away. These treatments are genuinely interesting, the biology behind growth factors is real, and anybody weighing a four-thousand-dollar out-of-pocket injection deserves a proper answer rather than a shrug.

So this page is that conversation, written out: what each treatment actually is, what the published trials found, and where the regulators stand. Most patients reach their own conclusion once they have all of it in front of them.

The idea behind all of them

It helps to see the common thread, because the marketing tends to obscure it.

Cartilage has a poor blood supply and limited capacity to repair itself. Every one of these treatments is an attempt to change that — to deliver something into the joint that provokes a biological response. The active ingredient everybody is chasing is growth factors.

Stem cells and BMAC

When a clinic offers “stem cell injections” using your own cells, this is usually what is meant: bone marrow aspirate concentrate, or BMAC.

The cells come from the flat bones of the pelvis. A large needle is passed into the bone, marrow is drawn out, spun down to concentrate the cell population, and injected into the joint. It is a real procedure using your own tissue, and of everything on this page it has the strongest evidence base.

What that evidence shows:

Equivalent, not superior. That is the finding, and it comes from randomized data rather than testimonial. Worth holding alongside the fact that BMAC costs several times what PRP does and requires a needle in your pelvis rather than a blood draw.

Amniotic and exosome products

These are a different category, and the distinction matters more than the marketing usually makes clear. These are donor products, not your own cells.

Amniotic

Derived from amniotic tissue or fluid. Frequently marketed as containing living stem cells, although processing generally leaves few or none that are viable. The FDA has taken enforcement action here, including ruling an amniotic-fluid-derived product an unapproved new drug and unlicensed biological product.

Exosomes

Not cells at all — exosomes are small vesicles released by cells. The FDA states that no exosome product has been approved for injection, systemic administration, or implantation in humans. Not one. The agency has issued warning letters to companies marketing them, as recently as this year.

Fat injections and prolotherapy

Adipose (fat) injections

Fat is harvested, usually by liposuction, processed to concentrate the cell population, and injected. Like BMAC it uses your own tissue, but with a different harvest and a different mix of cells. How extensively the fat is processed also determines how the FDA classifies the product, which is an active regulatory question.

Prolotherapy

The oldest of the group, and mechanically the odd one out. Rather than delivering cells or platelets, a dextrose solution is injected to provoke a local inflammatory response, on the theory that this prompts the body to repair the tissue. Different route — same destination.

Where the FDA stands

This is worth knowing before you spend anything, and it applies across the category rather than to any one clinic.

None of that means the underlying science is worthless. It means the products being sold have not cleared the bar that would let anyone promise you a result.

What these cost

Typically $3,000 to $5,000, out of pocket, with no insurance coverage. The price is set by whoever is offering it.

That belongs in the decision alongside the evidence. For BMAC specifically, you would be paying several times the cost of PRP for an outcome the randomized data describes as equivalent. When you are paying yourself, that comparison is a fair one to make.

Where that leaves PRP

Follow the thread back to the beginning. Every treatment on this page is trying to deliver growth factors into an arthritic joint. Platelets release growth factors.

That is why PRP is where I land with most patients — not because the other treatments are absurd, but because PRP reaches the same target with more evidence and less cost. The detail on how it works, who benefits, and what to expect is in PRP for arthritis, and the wider regenerative options I offer are set out on the regenerative medicine page.

For where injections sit in the wider picture, including cortisone and gel, see what to try before a joint replacement.